Gail Lewis Phillips

7PUBLICATIONS
46CO-AUTHORS
Epidemiology not elsewhere classifiedPharmaceutical delivery technologiesRehabilitation engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 02, 2023
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.

Carsten Denkert, Chiara Lambertini, Peter A Fasching

|Oct 28, 2021
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics.

Gail Lewis Phillips, Jun Guo, James R Kiefer

|Sep 21, 2021
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.

Kyung W Song, Kyle A Edgar, Emily J Hanan

|Apr 27, 2018
Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells.

Guangmin Li, Jun Guo, Ben-Quan Shen

Pageof 2